Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "Primary hyperoxaluria type 2"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Endothelial Function in a Sample Group of Patients From the ICARE Study
Condition: Cardiovascular Diseases
Intervention: Drug: Vitamin E 400IU/day
2 Recruiting Biobank Protocol, Rare Diseases Clinical Research Network
Conditions: Primary Hyperoxaluria;   Dent Disease;   APRT Deficiency;   Cystinuria
Intervention:

Indicates status has not been verified in more than two years